Altre lingue iCAD, Inc.

Azioni

ICAD

US44934S2068

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 25/04/2024			Variaz. 5gg	Var. 1 gen.
1,48 ^USD	-5,13%		-6,92%	-16,38%

11/04	ICAD, Inc. presenta al Simposio Annuale SBI le nuove funzionalità di Profound Cloud e della Workstation Profound Detection migliorata	CI
09/04	ICAD, Inc. e Densitas, Inc. collaborano per migliorare la salute del seno di precisione con soluzioni AI leader per la qualità della mammografia, il rilevamento del cancro e la valutazione del rischio	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

ICAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium	11/04
ICAD, Inc. Showcases New Profound Cloud, Enhanced Profound Detection Workstation Features at SBI Annual Symposium	11/04
ICAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation	09/04
ICAD, Inc. and Densitas, Inc. Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation	09/04
ICAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting	08/04
ICAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)	03/04
ICAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale	02/04
ICAD, Inc. Announces Commercial Availability of ProFound Cloud	02/04
ICAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists	19/03
Earnings Flash (ICAD) ICAD Posts Q4 Revenue $4.7M, vs. Street Est of $4.3M	12/03
ICAD, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	12/03
ICAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results	12/03
ICad to Present Three Mammography Studies at Radiology Conference; Shares Rise	28/02
ICAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings	28/02
ICAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)	27/02
ICAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024	27/02
ICAD, Inc. Appoints Hedvig Hricak to the Board of Directors	26/02
ICAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference	06/02
ICAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member	30/01
ICAD, Inc. Appoints Michael John Doyle to its Board of Directors	25/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue iCAD, Inc.

Azioni

ICAD

US44934S2068

Altre lingue

Filtri